{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:09:50Z","timestamp":1792130990790,"version":"4.4.0"},"reference-count":8,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Occup Environ Med"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>OBJECTIVES: To describe relative hazards in sectors of the beryllium industry, risk factors of beryllium disease and sensitisation related to work process were sought in a beryllium manufacturing plant producing pure metal, oxide, alloys, and ceramics. METHODS: All 646 active employees were interviewed; beryllium sensitisation was ascertained with the beryllium lymphocyte proliferation blood test on 627 employees; clinical evaluation and bronchoscopy were offered to people with abnormal test results; and industrial hygiene measurements related to work processes taken in 1984-93 were reviewed. RESULTS: 59 employees (9.4%) had abnormal blood tests, 47 of whom underwent bronchoscopy. 24 new cases of beryllium disease were identified, resulting in a beryllium disease prevalence of 4.6%, including five known cases (29\/632). Employees who had worked in ceramics had the highest prevalence of beryllium disease (9.0%). Employees in the pebble plant (producing beryllium metal) who had been employed after 1983 also had increased risk, with a prevalence of beryllium disease of 6.4%, compared with 1.3% of other workers hired in the same period, and a prevalence of abnormal blood tests of 19.2%. Logistic regression modelling confirmed these two risk factors for beryllium disease related to work processes and the dependence on time of the risk at the pebble plant. The pebble plant was not associated with the highest gravimetric industrial hygiene measurements available since 1984. CONCLUSION: Further characterisation of exposures in beryllium metal production may be important to understanding how beryllium exposures confer high contemporary risk of beryllium disease.<\/jats:p>","DOI":"10.1136\/oem.54.8.605","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T00:14:48Z","timestamp":1229472888000},"page":"605-612","source":"Crossref","is-referenced-by-count":125,"title":["Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant."],"prefix":"10.1136","volume":"54","author":[{"given":"K","family":"Kreiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Mroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Barna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1997,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"The epidemiology of beryllium sensitization and disease in nuclear workers","volume":"148","author":"Kreiss, K.; Mroz, M.M.; Zhen, B.; Martyny, J.W.; Newman, L.S.","year":"1993","unstructured":"Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman LS. The epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev RespirDis 1993;148:985-91.","journal-title":"Am Rev RespirDis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2, ug\/m'","volume":"30","author":"Kreiss, K.; Mroz, M.M.; Newman, L.S.; Martyny, J.W.; Zhen, B.","year":"1996","unstructured":"Kreiss K, Mroz MM, Newman LS, Martyny JW, Zhen B. Machining risk of beryllium disease and sensitization with median exposures below 2,ug\/m'. Am a Ind Med 1996;30:16-25.","journal-title":"Am a Ind Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPBI glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi, L.; Sorrentino, R.; Saltini, C.","year":"1993","unstructured":"Richeldi L, Sorrentino R, Saltini C. HLA-DPBI glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-4.","journal-title":"Science"},{"key":"ref_4","article-title":"Beryflium metal supply options","author":"National Materials Advisory Board, Commission on Engineering and Technical Systems, National Research Council","year":"1989","unstructured":"National Materials Advisory Board, Commission on Engineering and Technical Systems, National Research Council. Beryflium metal supply options. Washington, DC: National Academy Press, NMAB-452, 1989."},{"issue":"118","key":"ref_5","first-page":"1","article-title":"Epidemiology standardization project","volume":"1978","author":"Ferris, B.G.","unstructured":"Ferris BG. Epidemiology standardization project. Am Review Respir Dis 1978-118: 1-120.","journal-title":"Am Review Respir Dis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease","volume":"88","author":"Mroz, M.M.; Kreiss, K.; Lezotte, D.C.; Campbell, P.A.; Newman, I.S.","year":"1991","unstructured":"Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman IS. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Alleg Clin Immunol 1991;88:54-60.","journal-title":"J Alleg Clin Immunol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history","volume":"139","author":"Newman, L.S.; Kreiss, K.; King, T.E.; Seay, S.; Campbell, P.A.","year":"1989","unstructured":"Newman LS, Kreiss K, King TE, Seay S, Campbell PA. Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis 1989;139: 1479-86.","journal-title":"Am Rev Respir Dis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1378\/chest.77.3.400","article-title":"Transbronchoscopic lung biopsy in sarcoidosis","volume":"77","year":"1980","unstructured":"Roethe RA, Fuller PB, Byrd RB, Hafermann DR. Transbronchoscopic lung biopsy in sarcoidosis. Chest 1980;77:400-2.","journal-title":"Chest"}],"container-title":["Occupational and Environmental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/oem.54.8.605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T16:38:43Z","timestamp":1716482323000},"score":1,"resource":{"primary":{"URL":"https:\/\/oem.bmj.com\/lookup\/doi\/10.1136\/oem.54.8.605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":8,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1997,8,1]]},"published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1136\/oem.54.8.605"],"URL":"https:\/\/doi.org\/10.1136\/oem.54.8.605","relation":{},"ISSN":["1351-0711","1470-7926"],"issn-type":[{"value":"1351-0711","type":"print"},{"value":"1470-7926","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}